Polyhedral Oligosilsesquioxane Frameworks
FULL PAPER
142.2 (C; 1,2,3-triazole), 167.2 ppm (C=O; phthalimido); 29Si NMR
(79.5 MHz, [D6]DMSO): d=À66.6 ppm; HRMS (ESI): m/z calcd for
Method C: [CuACHTUGNTERNNU(G C186tren)]Br (43 mg, 0.024 mmol) and iPr2NEt (135 mL,
0.775 mmol) were added to a solution of 6 (51 mg, 0.047 mmol) and 7 f[89]
(144 mg, 0.483 mmol) in toluene (5 mL) under argon. After stirring for
8 h at 808C under microwave irradiation, a white precipitate was formed.
The solvent was removed under reduced pressure and the residue was
purified by flash column chromatography (CH2Cl2/MeOH 10:1) to afford
8 f as a white powder (127 mg, 78%).
C
112H105N32O28Si8: 2569.5930 [M+H+]; found: 2569.5841.
Octakis[(3-ACHTUNGTRENNUNG(4’-(hydroxymethyl)-1’H-1’,2’,3’-triazol-1’-yl)propyl)]octasilses-
quioxane (8c)
Method C: [CuACHTUNGTRENNUNG(C186tren)]Br (17 mg, 0.009 mmol) and iPr2NEt (66 mL,
0.378 mmol) were added to a solution of 6 (20 mg, 0.018 mmol) and prop-
argyl alcohol (11 mL, 0.189 mmol) in toluene (1.0 mL) under argon. After
heating for 3 h at 808C under microwave irradiation, a white precipitate
was formed. The precipitate was dissolved in MeOH (2 mL), the solution
was extracted with hexane (3ꢄ3 mL), and the methanol layer was con-
centrated under reduced pressure to afford 8c as a colorless oil (18.5 mg,
67%). Using THF/H2O (2:1) instead of toluene in this procedure gave
8c in 77% yield, after stirring the reaction for 25 h at RT. 1H NMR
(400 MHz, CD3OD): d=0.59–0.63 (m, 16H; SiCH2), 1.92–1.98 (m, 16H;
SiCH2CH2), 4.39 (t, 16H, J=6.8 Hz; SiCH2CH2CH2), 4.69 (s, 16H;
CH2OH), 7.93 ppm (s, 8H; 1,2,3-triazole); 13C NMR (100 MHz, CD3OD):
d=9.5 (SiCH2), 25.2 (SiCH2CH2), 53.4 (SiCH2CH2CH2), 56.6 (CH2OH),
124.5 (CH; 1,2,3-triazole), 149.2 ppm (C; 1,2,3-triazole); HRMS (ESI):
m/z calcd for C48H81N24O20Si8: 1537.4213 [M+H+]; found: 1537.4253.
Method D: A solution of CuSO4·5H2O (2.5 mg, 0.010 mmol) and sodium
ascorbate (9 mg, 0.045 mmol) in water (0.5 mL) was added to a solution
of
6
(20 mg, 0.018 mmol) and 7 f[89] (53 mg, 0.178 mmol) in CH2Cl2
(0.5 mL). After stirring for 2 h at RT, a saturated aqueous solution of
EDTA (1 mL) was added, the mixture was vigorously stirred for 30 min,
the phases were separated, and the aqueous layer was extracted with
CH2Cl2 (2ꢄ2 mL). The organic layers were combined, dried over
Na2SO4, and the solvent was removed under reduced pressure. The crude
product was purified by flash column chromatography (CH2Cl2/MeOH
10:1) to afford 8 f as a white powder (53 mg, 85%). M.p. (CH2Cl2) 118–
1228C; 1H NMR (400 MHz, CDCl3): d=0.57–0.61 (m, 16H; Si-
CH2CH2CH2), 1.25 (s, 24H; C
N
ACHTUGNTREN(UNNG CH3)2), 1.45 (s,
24H; (CH3)2), 1.47 (s, 24H;
C
N
CACHTUNGTRENNUNG
SiCH2CH2CH2), 3.51–3.60 (m, 8H; H-5’’), 3.66–3.67 (m, 8H; H-4’’), 3.70
(t, 8H, J=10.5 Hz; H-6a’’), 3.82 (dd, 8H, J=5.6, 10.5 Hz; H-6b’’), 4.05
(dd, 8H, J=5.4, 7.8 Hz; H-3’’), 4.11 (d, 8H, J=5.4 Hz; H-2’’), 4.27 (t,
16H, J=7.1 Hz; SiCH2CH2CH2), 4.60 (d, 8H, J=12.2 Hz; CH2O-C-1’’),
4.77 (d, 8H, J=12.2 Hz; CH2O-C-1’’), 5.09 (s, 1H; H-1’’), 7.72 ppm (s,
8H; CH of 1,2,3-triazole); 13C NMR (100 MHz, CDCl3): d=8.9
Octakis[3-ACHTUNGTRENNUNG(4’-(4’’-hydroxybutyl)-1’H-1’,2’,3’-triazol-1’-yl]propyl)silses-
quioxane (8d)
Method C: [CuACHTUNGTRENNUNG(C186tren)]Br (17 mg, 0.009 mmol) and iPr2NEt (66 mL,
0.378 mmol) were added to a solution of 6 (20 mg, 0.018 mmol) and 5-
hexyn-1-ol (21 mL, 0.190 mmol) in toluene (1 mL), under argon. After
heating for 3 h at 808C under microwave irradiation, a white precipitate
was formed. The precipitate was dissolved in MeOH (2 mL), the solution
was extracted with hexane (3ꢄ5 mL), and the methanol layer was con-
centrated under reduced pressure to afford 8d (24 mg, 71%) as a color-
less oil. Using THF/H2O (2:1) instead of toluene in this procedure gave
8d in 80% yield after stirring the reaction for 25 h at RT. 1H NMR
(400 MHz, [D6]DMSO): d=0.45 (brs, 16H; SiCH2), 1.39–1.47 (m, 16H;
CH2CH2CH2CH2OH), 1.53–1.63 (m, 16H; CH2CH2CH2CH2OH), 1.75
(brs, 16H; SiCH2CH2), 2.55–2.60 (m, 16H; CH2CH2CH2CH2OH), 3.37
(brs, 16H; CH2CH2CH2CH2OH), 4.22 (brs, 16H; SiCH2CH2CH2), 4.39
(brs, 16H; CH2CH2CH2CH2OH), 7.79 ppm (s, 8H; 1,2,3-triazole);
13C NMR (100 MHz, [D6]DMSO): d=9.2 (SiCH2; data obtained from the
HSQC spectrum), 24.1 (SiCH2CH2), 25.5 (CH2CH2CH2CH2OH), 26.3
(SiCH2CH2CH2), 19.0 (C
28.4 (C(CH3)2), 29.3 (C(CH3)2), 52.4 (SiCH2CH2CH2), 60.5 (CH2O-C-1’’),
61.8 (C-5’’), 62.2 (C-6’’), 72.8 (C-4’’), 75.0 (C-3’’), 76.1 (C-2’’), 97.2 (C-1’’),
CAHTUTGNRENG(UN CH3)2), 24.2 (SiCH2CH2CH2), 26.4 (CACHTUNGTRENNUNG(CH3)2),
A
ACHTUNGTRENNUNG
99.9 (CACTHNUTRGENNUG(CH3)2), 109.7 (CAHCUTNTGERN(NUGN CH3)2), 123.6 (CH of 1,2,3-triazole), 143.9 ppm
(C of 1,2,3-triazole); 29Si NMR (79.5 MHz, CDCl3): d=À67.3 ppm; MS
(MALDI-TOF; 2,5-dihydroxybenzoic acid matrix): m/z: 3496 [M+Na+];
HRMS (ESI): m/z calcd for C144H226N24O60Si8: 1737.6762 [(M+2H)2+];
found: 1737.6858.
Octakis{3-ACTHUNRTGNEUNG[4’-((a-d-mannopyranos-1’-yl)methyl)-1’H-1’,2’,3’-triazol-1’-yl]-
propyl}octasilsesquioxane (8g): Trifluoroacetic acid (25 mL, 0.324 mmol)
was added to a solution of 8 f (54 mg, 0.015 mmol) in THF/H2O (4:1)
(2 mL). After stirring for 3 h at RT, compound 8g was isolated as a white
precipitate (38 mg, 90%), m. p. (H2O) 112–1168C; 1H NMR (500 MHz,
D2O): d=0.32–0.44 (m, 16H; Si-CH2CH2CH2), 1.74–1.78 (m, 16H;
SiCH2CH2CH2), 3.47–3.78 (m, 48H; H-2’’, H-3’’, H-4’’, H-5’’, H-6a’’, and
H-6b’’), 4.14–4.30 (m, 16H; SiCH2CH2CH2), 4.61–4.68 (m, 16H;
CH2CCH), 4.80 (s, 8H; H-1’’), 7.90 ppm (brs, 8H; 1,2,3-triazole); 13C
NMR (125 MHz, [D6]DMSO): d=10.7 (SiCH2CH2CH2; data obtained
from HSQC spectrum), 25.2 (SiCH2CH2CH2), 53.46 (SiCH2CH2CH2),
61.0 (OCH2-triazole), 62.3 (C-6’’), 68.1 (C-4’’), 71.4 (C-2’’), 71.9 (C-3’’),
74.5 (C-5’’), 100.7 (C-1’’), 126.4 (CH in triazole), 145.0 ppm (C in tria-
zole); MS (MALDI-TOF, 2,5-dihydroxybenxoic acid matrix): m/z: 2855
[M+Na]+; HRMS (ESI): m/z: calcd for C97H161N23NaO60Si8: 2855.8258
[M+Na]+; found: 2855.8253.
(CH2CH2CH2CH2OH),
32.7
(CH2CH2CH2CH2OH),
51.7
(SiCH2CH2CH2), 61.1 (CH2CH2CH2CH2OH), 122.3 (CH; 1,2,3-triazole),
147.6 ppm (C; 1,2,3-triazole); HRMS (ESI): m/z calcd for
C72H129N24O20Si8: 1873.7969 [M+H+]; found: 1873.7951.
Octakis[3-
sesquioxane (8e)
Method C: [Cu(C186tren)]Br (17 mg, 0.009 mmol) and iPr2NEt (66 mL,
ACHTUNGTRENNUNG(4’-(methoxycarbonyl)-1’H-1’,2’,3’-triazol-1’-yl)propyl]octasil-
ACHTUNGTRENNUNG
0.378 mmol) were added to a solution of 6 (20 mg, 0.018 mmol) and
methyl propiolate (16 mL, 0.180 mmol) in toluene (1 mL) under argon.
After heating for 8 h at 808C under microwave irradiation, a white pre-
cipitate was formed. The reaction mixture was dissolved in MeOH and
the product was precipitated by addition of CHCl3 to afford 8e (28 mg,
88%) as a white powder. M.p. (CHCl3) 125–1278C; 1H NMR (400 MHz,
CDCl3): d=0.54–0.59 (m, 16H; SiCH2), 1.97–2.02 (m, 16H; SiCH2CH2),
3.93 (s, 24H; COOCH3), 4.42 (t, 16H, J=6.7 Hz; SiCH2CH2CH2),
8.24 ppm (s, 8H; 1,2,3-triazole); 13C NMR (100 MHz, CDCl3): d=8.3
(SiCH2), 23.7 (SiCH2CH2), 52.2 (SiCH2CH2CH2), 52.4 (COOCH3), 127.9
(CH; 1,2,3-triazole), 139.8 (C; 1,2,3-triazole), 161.1 ppm (COOCH3);
29Si NMR (79.5 MHz, CDCl3) d=À67.4 ppm; HRMS (ESI): m/z calcd
for C56H81N24O28Si8: 1761.3806 [M+H+]; found: 1761.3796.
Octakis(3-ACTHNUGTRENNUG{4’-CAHTUNGTREN[NUNG 4”-(2’’’,8’’’-diethyl-5’’’,5’’’-difluoro-1’’’,3’’’,7’’’,9’’’-tetramethyl-
dipyrrolo[1’’’,2’’’c:2’’’,1’’’f][1’’’,3’’’,2’’’]diazaborinin-4’’’-ium-5’’’-uid-10’’’-yl)-
phenyl]-1’H-1’,2’,3’-triazol-1’-yl}propyl)octasilsesquioxane (8h)
Method D: A solution of CuSO4·5H2O (2.5 mg, 0.010 mmol) and sodium
ascorbate (9 mg, 0.045 mmol) in water (0.6 mL) was added to a solution
of 6 (20 mg, 0.018 mmol) and 8h[90] (72 mg, 0,178 mmol) in CH2Cl2
(0.9 mL). After stirring for 4.5 h at RT, a saturated aqueous solution of
EDTA (1 mL) was added, the mixture was vigorously stirred for 30 min,
the phases were separated, and the aqueous layer was extracted with
CH2Cl2 (2ꢄ3 mL). The organic layers were combined, dried over
Na2SO4, and the solvent was removed under reduced pressure. The crude
product was purified by flash column chromatography (hexane/EtOAc
5:1) to afford 8h as a red powder (54 mg, 70%). M.p. (CH2Cl2) 2908C
Octakis{3-ACHTUNGTRENNUNG[4’-((2’’,3’’,4’’,6’’-di-O-isopropylidene-a-d-mannopyranos-1’’-yl)-
methyl)-1’H-1’,2’,3’-triazol-1’-yl]propyl}octasilsesquioxane (8 f)
Method A: (EtO)3P·CuI (5 mg, 0.014 mmol) and iPr2NEt (91 mL,
0.522 mmol) were added to a solution of 6 (35 mg, 0.032 mmol) and 7 f[89]
(86 mg, 0.288 mmol) in THF (1 mL) under argon. After stirring for 9 h at
808C under microwave irradiation, the solvent was removed under re-
duced pressure and the residue was purified by flash column chromatog-
raphy (CH2Cl2/MeOH 10:1) to afford 8 f as a white powder (70 mg,
63%).
1
(decomposition); H NMR (400 MHz, CDCl3): d=0.68–0.75 (m, 16H; Si-
CH2CH2CH2), 0.93 (t, 48H, J=7.4 Hz; 16ꢄ(CH3CH2), 1.30 (s, 48H; 16ꢄ
CH3-C), 2.13–2.18 (m, 16H; SiCH2CH2CH2), 2.25 (q, 32H, J=7.4 Hz;
16ꢄCH2CH3), 2.51 (s, 48H; 16ꢄCH3-C), 4.46 (t, 16H, J=6.9 Hz;
SiCH2CH2CH2), 7.32 (d, 16H, J=8.2 Hz; 2ꢄCH Ar), 8.01 (d, 16H, J=
Chem. Eur. J. 2010, 16, 3833 – 3841
ꢃ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3839